Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03649347 · ClinicalTrials.gov registry record · NA
Bringing Exposure Therapy to Real-Life Context With Augmented Reality
A NA study, sponsored by Wayne State University.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03649347 is a NA study that was terminated before completion, run by Wayne State University. The registered enrollment target is 25 participants.
The verdict
NCT03649347, a NA study, was terminated before completion, sponsored by Wayne State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
In this patented project, U.S. Patent No. 10,839,707, the investigators will develop an augmented reality exposure therapy method for arachnophobia, and fear of snakes, to test in the clinic. The platform will include a software that allows the clinician (psychiatrist/therapist) to position virtual objects in the real environment of the patient with the above mentioned phobias while the patient is wearing the augmented reality (AR) device. Then the clinician will lead the patient through steps of exposure therapy to the fear objects. The investigators will then measure the impact of treatment and compare to before treatment measures of fear of the phobic object. Exposure therapy is the most evidence-based treatment for specific phobias, social phobia, obsessive-compulsive disorder (OCD), and posttraumatic stress disorder (PTSD). The core principle is patient's exposure to the feared objects/situations guided by a clinician. For example, in arachnophobia, patient is exposed to pictures of spiders printed or on a computer screen- or if available, view of a real tarantula in the office. Gradually, patient tolerates viewing/approaching the spider from a closer distance, and fear response extinguishes. The clinician has a crucial role in signaling safety to the patient, as well as providing support and coaching. This treatment is limited by multiple factors: 1) limited access to feared objects/situations in the clinic, 2) even when feared objects are available, they are not diverse (e.g. different types and colors of spiders), which limits generalization of safety learning, 3) when available, clinician has very limited control over behaviors of the feared objects (e.g. spider/snake), 4) safety learning is limited to the clinic office context, and contextualization of safety learning to real life experiences is left to the patient to do alone, which often does not happen. This is specifically important in conditions such as PTSD, where there is cumulative evidence for im
Interventions
- BEHAVIORAL Augmented reality exposure therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-08-30 |
| Est. Completion | 2020-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03649347
The ClinicalTrials.gov registry entry for NCT03649347 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Augmented reality exposure therapy is the first listed.
NCT03649347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03649347 about?
NCT03649347 is a clinical study titled "Bringing Exposure Therapy to Real-Life Context With Augmented Reality". In this patented project, U.S. Patent No. 10,839,707, the investigators will develop an augmented reality exposure therapy method for arachnophobia, and fear of snakes, to test in the clinic. The platform will include a software that allows the clinician (psychiatrist/therapist) to position virtual ...
What is the current status of trial NCT03649347?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2018-08-30. Estimated completion is 2020-04-01.
What interventions are being tested in trial NCT03649347?
The interventions under investigation include: Augmented reality exposure therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03649347?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.